Parkinson DiseaseACTIPARKNCT03244813
Evaluation of the Impact of a Personalized Program of Adapted Physical Activates in Patients With Parkinson Disease
A study testing Personalized activity program in people with Parkinson Disease, run by Centre Hospitalier Universitaire de Nīmes at 1 site in France.
Trial summary
Our study aims to compare the effects of a standard care plan to one using adapted physical activity in patients with Parkinson Disease. Using actigraphy as an evaluation measure will allow the collection of quantitative and objective data related to activity in contrast to questionnaires which are more subjective and… Read more about this study
- Who is it for?
- Ages 40 to 80 years
- Conditions the study is for
- Parkinson Disease
- What is being tested?
- Personalized activity program
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 19 participants
- Where
- 1 siteFrance
- Study dates
- 10 Jan 2018to 2 Dec 2019
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 40 to 80 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- The patient and their carer have given their free and informed consent and signed the consent form
- The patient must be insured of the beneficiary of an insurance policy
- The patient is available for the 6 month follow-up
- The patient is between 40 and 80 years old
- The patient has experienced symptoms of Parkinson Disease for at least 5 years and is in a stable state (no medical event or change of treatment in at least 1 month)
- The functional impact and duration of fluctuations is ≥3 (MDS UPDRS)
Show all 9Show fewer
- The patient can walk autonomously, including using a technical aid
- The patient does not have any regular physical activity excluding physiotherapy sessions
- The patient has daily help from a caregiver
Who cannot join
- The subject and/or their caregiver is participating in another study
- The subject and/or their caregiver is in a period of exclusion determined by a previous study
- The patients is under judicial protection or state guardianship
- It proves impossible to give the patient and/or the caregiver clear information
- The patients and/or the caregiver reuses to sign the consent form
- The patient is pregnant or breast feeding
Show all 9Show fewer
- The patient has anxiety or depression (Score HAD≥ 11/14), cardiac or respiratory failure (stress test), vesico-sphincter problems preventing normal practice of a physical activity, a contraindication to adapted physical activities
- The patient cannot walk
- Muscular tremor preventing the actigraphy measurement. Outside normal range values for UPDRS measures of: 3.15) postural tremor of the hands; 3.16) action tremor of the hands; 3.17) amplitude of rest tremor
Trial locations and contacts
1 site in 1 country.
About this study
Our study aims to compare the effects of a standard care plan to one using adapted physical activity in patients with Parkinson Disease. Using actigraphy as an evaluation measure will allow the collection of quantitative and objective data related to activity in contrast to questionnaires which are more subjective and dependent on self-representation. In addition, the evaluation of the caregiver's actigraphy and hardship (Zarit scale) will provide interesting data from this population.
- Conditions
- Parkinson Disease
- Being tested
- Personalized activity program
- Medical subject headings
- Parkinson Disease
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Personalized activity programOther
Targeted physical activity
| Study group | Role | What they receive |
|---|---|---|
| Adapted physical activity | Experimental | Not described Receives: Other: Personalized activity program |
| Standard care | No intervention | Not described |
What is being measured
The primary outcome is the main question the study is designed to answer.
Evaluate the impact of an adapted physical activity (APA) program versus standard care on the activity of patients with Parkinson Disease
previous weeks' activity measured by actigraphy
Measured: 3 months
Secondary outcomes (22)
Activity of patients in both groups
previous weeks' activity measured by actigraphy
Measured: 6 months
Activity of patients in both groups
assessed by international physical activity questionnaire
Measured: 6 months
Quality of life of patients undertaking APA verses standard care
Assessed by PDG-39 questionnaire
Measured: 3 months
Quality of life of patients undertaking APA verses standard care
Assessed by PDG-39 questionnaire
Measured: 6 months
Risk of fall of patients undertaking APA verses standard care
measured by Timed Up and Go test
Measured: 3 months
Risk of fall of patients undertaking APA verses standard care
measured by Timed Up and Go test
Measured: 6 months
Risk of fall of patients undertaking APA verses standard care
measured by Tinetti Falls Efficacy Scale
Measured: 3 months
Risk of fall of patients undertaking APA verses standard care
measured by Tinetti Falls Efficacy Scale
Measured: 6 months
Risk of fall of patients undertaking APA verses standard care
measured by 0-10 scale
Measured: 3 months
Risk of fall of patients undertaking APA verses standard care
measured by 0-10 scale
Measured: 6 months
Endurance and speed of walking of patients undertaking APA verses standard care
6 minute walk test
Measured: 3 months
Endurance and speed of walking of patients undertaking APA verses standard care
6 minute walk test
Measured: 6 months
Activity of the care giver
previous weeks' activity measured by actigraphy
Measured: 3 months
Activity of the care giver
previous weeks' activity measured by actigraphy
Measured: 6 months
Evaluation of the care burden of care giver
Zarit scale
Measured: 3 months
Evaluation of the care burden of care giver
Zarit scale
Measured: 6 months
Grip strength
Pinch test
Measured: Day 0
Grip strength
Pinch test
Measured: 6 months
Patient dependence
Activities of Daily Living
Measured: Day 0
Patient dependence
Activities of Daily Living
Measured: 6 months
Level of dementia at Day
Instrumental Activities of Daily Living
Measured: Day 0
Level of dementia at Day
Instrumental Activities of Daily Living
Measured: 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted10 Aug 2017
- Study start10 Jan 2018
- Primary completion2 Dec 2019
- Study completion2 Dec 2019
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for Parkinson DiseaseStudies of the same condition, open and under way.
- More trials run by Centre Hospitalier Universitaire de NīmesThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 19 participants (actual)
Sponsor and investigators
- Lead sponsor
- Centre Hospitalier Universitaire de Nīmes
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03244813
- Sponsor's protocol ID
- NIMAO/2016/EV-01
- Acronym
- ACTIPARK
- Status last verified
- Jan 2020
- First submitted
- 16 Jun 2017
- Last updated
- 27 Jan 2020
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Ernst M, Folkerts AK, Gollan R, Lieker E, Caro-Valenzuela J, Adams A, Cryns N, Monsef I, Dresen A, Roheger M, Eggers C, Skoetz N, Kalbe E. Physical exercise for people with Parkinson's disease: a systematic review and network meta-analysis. Cochrane Database Syst Rev. 2024 Apr 8;4(4):CD013856. doi: 10.1002/14651858.CD013856.pub3.
PubMed 38588457Ernst M, Folkerts AK, Gollan R, Lieker E, Caro-Valenzuela J, Adams A, Cryns N, Monsef I, Dresen A, Roheger M, Eggers C, Skoetz N, Kalbe E. Physical exercise for people with Parkinson's disease: a systematic review and network meta-analysis. Cochrane Database Syst Rev. 2023 Jan 5;1(1):CD013856. doi: 10.1002/14651858.CD013856.pub2.
PubMed 36602886
Study at a glance
From the registry record, last updated by the sponsor on 27 Jan 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluation of the Impact of a Personalized Program of Adapted Physical Activates in Patients With Parkinson Disease
- ClinicalTrials.gov ID
- NCT03244813
- Acronym / sponsor ID
- ACTIPARK / NIMAO/2016/EV-01
- Conditions
- Parkinson Disease
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 19 participants (actual)
- Lead sponsor
- Centre Hospitalier Universitaire de NīmesUniversity, hospital or other
- Study start
- 10 Jan 2018 (actual)
- Primary completion
- 2 Dec 2019 (actual)
- Study completion
- 2 Dec 2019 (actual)
- First posted
- 10 Aug 2017 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Our study aims to compare the effects of a standard care plan to one using adapted physical activity in patients with Parkinson Disease. Using actigraphy as an evaluation measure will allow the collection of quantitative and objective data related to activity in contrast to questionnaires which are more subjective and dependent on self-representation. In addition, the evaluation of the caregiver's actigraphy and hardship (Zarit scale) will provide interesting data from this population.
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Adapted physical activity | Experimental | Other: Personalized activity program |
| Standard care | No intervention | – |
Who may qualify
- Ages
- 40 to 80 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (9 listed)
- The patient and their carer have given their free and informed consent and signed the consent form
- The patient must be insured of the beneficiary of an insurance policy
- The patient is available for the 6 month follow-up
- The patient is between 40 and 80 years old
- The patient has experienced symptoms of Parkinson Disease for at least 5 years and is in a stable state (no medical event or change of treatment in at least 1 month)
Key exclusion criteria (9 listed)
- The subject and/or their caregiver is participating in another study
- The subject and/or their caregiver is in a period of exclusion determined by a previous study
- The patients is under judicial protection or state guardianship
- It proves impossible to give the patient and/or the caregiver clear information
- The patients and/or the caregiver reuses to sign the consent form
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Personalized activity programTargeted physical activity | Other | Adapted physical activity |
Primary outcome
Evaluate the impact of an adapted physical activity (APA) program versus standard care on the activity of patients with Parkinson Disease
Time frame: 3 months
previous weeks' activity measured by actigraphy
22 secondary outcomes
Activity of patients in both groups
Time frame: 6 months
Activity of patients in both groups
Time frame: 6 months
Quality of life of patients undertaking APA verses standard care
Time frame: 3 months
Quality of life of patients undertaking APA verses standard care
Time frame: 6 months
Risk of fall of patients undertaking APA verses standard care
Time frame: 3 months
Risk of fall of patients undertaking APA verses standard care
Time frame: 6 months
Risk of fall of patients undertaking APA verses standard care
Time frame: 3 months
Risk of fall of patients undertaking APA verses standard care
Time frame: 6 months
Risk of fall of patients undertaking APA verses standard care
Time frame: 3 months
Risk of fall of patients undertaking APA verses standard care
Time frame: 6 months
Endurance and speed of walking of patients undertaking APA verses standard care
Time frame: 3 months
Endurance and speed of walking of patients undertaking APA verses standard care
Time frame: 6 months
Activity of the care giver
Time frame: 3 months
Activity of the care giver
Time frame: 6 months
Evaluation of the care burden of care giver
Time frame: 3 months
Evaluation of the care burden of care giver
Time frame: 6 months
Grip strength
Time frame: Day 0
Grip strength
Time frame: 6 months
Patient dependence
Time frame: Day 0
Patient dependence
Time frame: 6 months
Level of dementia at Day
Time frame: Day 0
Level of dementia at Day
Time frame: 6 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 27 Jan 2020.
- Derived from this study: PubMed 38588457Ernst M, Folkerts AK, Gollan R, Lieker E, Caro-Valenzuela J, Adams A, Cryns N, Monsef I, Dresen A, Roheger M, Eggers C, Skoetz N, Kalbe E. Physical exercise for people with Parkinson's disease: a systematic review and network meta-analysis. Cochrane Database Syst Rev. 2024 Apr 8;4(4):CD013856. doi: 10.1002/14651858.CD013856.pub3.
- Derived from this study: PubMed 36602886Ernst M, Folkerts AK, Gollan R, Lieker E, Caro-Valenzuela J, Adams A, Cryns N, Monsef I, Dresen A, Roheger M, Eggers C, Skoetz N, Kalbe E. Physical exercise for people with Parkinson's disease: a systematic review and network meta-analysis. Cochrane Database Syst Rev. 2023 Jan 5;1(1):CD013856. doi: 10.1002/14651858.CD013856.pub2.
- Individual participant dataSharing planned: No
Related trials for Parkinson Disease
Not yet recruitingPhase 1/2
STAR0602 With Nivolumab in Non Small Cell Lung Cancer and in Metastatic Castrate-Resistant Prostate Cancer, and STAR0602 Alone in Thymic Carcinoma
NSCLC, Non-Small Cell Lung Cancer
Enrolling by invitationObservational study
Early Molecular Biomarkers for Differentiating Parkinsonian Syndromes
PARKINSON DISEASE (Disorder), Atypical Parkinsonism
RecruitingPhase 3
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
Cervical Cancer
Active, not recruitingPhase 1/2
Clinical Safety and Efficacy of Umbilical Cord Mesenchymal Stromal Cells-derived Exosomes in Patients With Parkinson's Disease
Parkinson Disease (PD)
Active, not recruitingObservational study
Adaptive DBS to Offset STN Dysregulation During Exercise in PD
Parkinson Disease
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Personalized activity program in people with Parkinson Disease, run by Centre Hospitalier Universitaire de Nīmes at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 9 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 27 Jan 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Evaluate the impact of an adapted physical activity (APA) program versus standard care on the activity of patients with Parkinson Disease (time frame: 3 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03244813, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Jan 2020.